Arvee Laboratories (India) Inkomsten in het verleden
Verleden criteriumcontroles 1/6
Arvee Laboratories (India)'s earnings have been declining at an average annual rate of -1.5%, while the Chemicals industry saw earnings growing at 15.6% annually. Revenues have been declining at an average rate of 3% per year. Arvee Laboratories (India)'s return on equity is 5.2%, and it has net margins of 4.5%.
Belangrijke informatie
-1.5%
Groei van de winst
-3.9%
Groei van de winst per aandeel
| Chemicals Groei van de industrie | 17.7% |
| Inkomstengroei | -3.0% |
| Rendement op eigen vermogen | 5.2% |
| Nettomarge | 4.5% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Here's Why We Think Arvee Laboratories (India) (NSE:ARVEE) Might Deserve Your Attention Today
Aug 08
Here's Why We Think Arvee Laboratories (India) (NSE:ARVEE) Is Well Worth Watching
Apr 13Do Arvee Laboratories (India)'s (NSE:ARVEE) Earnings Warrant Your Attention?
Dec 22We Ran A Stock Scan For Earnings Growth And Arvee Laboratories (India) (NSE:ARVEE) Passed With Ease
Sep 16Subdued Growth No Barrier To Arvee Laboratories (India) Ltd.'s (NSE:ARVEE) Price
Aug 13Calculating The Intrinsic Value Of Arvee Laboratories (India) Ltd. (NSE:ARVEE)
Apr 19Opbrengsten en kosten
Hoe Arvee Laboratories (India) geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 334 | 15 | 40 | 0 |
| 31 Mar 24 | 303 | 11 | 60 | 0 |
| 31 Dec 23 | 284 | 9 | 45 | 0 |
| 30 Sep 23 | 369 | 16 | 51 | 0 |
| 30 Jun 23 | 519 | 35 | 62 | 0 |
| 31 Mar 23 | 613 | 41 | 62 | 0 |
| 31 Dec 22 | 698 | 49 | 58 | 0 |
| 30 Sep 22 | 615 | 45 | 57 | 0 |
| 30 Jun 22 | 494 | 32 | 57 | 0 |
| 31 Mar 22 | 400 | 26 | 57 | 0 |
| 31 Dec 21 | 369 | 22 | 42 | 0 |
| 30 Sep 21 | 489 | 32 | 43 | 0 |
| 30 Jun 21 | 477 | 27 | 34 | 0 |
| 31 Mar 21 | 474 | 27 | 56 | 0 |
| 31 Dec 20 | 475 | 28 | 24 | 0 |
| 30 Sep 20 | 369 | 17 | 37 | 0 |
| 30 Jun 20 | 407 | 21 | 74 | 0 |
| 31 Mar 20 | 454 | 23 | 28 | 0 |
| 31 Dec 19 | 478 | 25 | 62 | 0 |
| 30 Sep 19 | 501 | 27 | 54 | 0 |
| 30 Jun 19 | 525 | 25 | 55 | 0 |
| 31 Mar 19 | 549 | 23 | 55 | 0 |
| 30 Jun 18 | 549 | 14 | 64 | 0 |
| 31 Mar 18 | 478 | 11 | 62 | 0 |
| 31 Mar 17 | 344 | 16 | 33 | 0 |
| 31 Mar 16 | 268 | 2 | 26 | 0 |
| 31 Mar 15 | 130 | -16 | 19 | 0 |
| 31 Mar 14 | 118 | 0 | 8 | 0 |
Kwaliteitswinsten: ARVEE has high quality earnings.
Groeiende winstmarge: ARVEE's current net profit margins (4.5%) are lower than last year (6.7%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: ARVEE's earnings have declined by 1.5% per year over the past 5 years.
Versnelling van de groei: ARVEE's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: ARVEE had negative earnings growth (-56.5%) over the past year, making it difficult to compare to the Chemicals industry average (10.4%).
Rendement op eigen vermogen
Hoge ROE: ARVEE's Return on Equity (5.2%) is considered low.